ICON8: Outcome in progression-free survival for weekly-dose paclitaxel in first-line ovarian cancer
CABOSUN trial of cabozantinib - could it change how we treat frontline RCC?
The nurse's perspective on looking after lung cancer patients receiving immunotherapy
Metastatic colorectal cancer: trifluridine/ tiripacil or regorafenib?
The APHINITY debate: should we change our treatment of breast cancer?